Lucid Diagnostics (LUCD) Treasury Shares (2021 - 2026)

Lucid Diagnostics' Treasury Shares history runs 6 years deep, the most recent figure standing at $12.3 million for Q1 2026.

• Quarterly Treasury Shares rose 86.74% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (up 86.74% YoY) and the FY2025 annual result came in at $6.6 million, up 68.94% from the prior year.
• Treasury Shares was $12.3 million for Q1 2026 at Lucid Diagnostics, up from $6.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $12.3 million in Q1 2026 and bottomed at $1.8 million in Q3 2023.
• A 5-year average of $4.1 million and a median of $2.3 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares retreated 17.19% — and 2025, when it soared 186.59%.
• Lucid Diagnostics' Treasury Shares stood at $2.1 million in 2022, then increased by 11.76% to $2.3 million in 2023, then jumped by 66.74% to $3.9 million in 2024, then surged by 68.94% to $6.6 million in 2025, then jumped by 86.74% to $12.3 million in 2026.
• Business Quant data shows LUCD's Treasury Shares at $12.3 million in Q1 2026, $6.6 million in Q4 2025, and $6.6 million in Q3 2025.